Omnicare Pays $4.2M To End FCA Suit Over Amgen Kickbacks

Omnicare Inc. will pay $4.2 million to settle a whistleblower's False Claims Act suit alleging it solicited and received kickbacks to promote Amgen Inc.'s Aranesp anemia drug among Medicaid patients, the U.S. Department of Justice said Thursday ...read more

  • Tags: